The National Institutes of Health is permanently closing one of two pharmacies that had issues with sterility processes, according to an article on The Wall Street Journal website.
The facilities received critical reports of their sterility processes a year ago from the Food and Drug Administration.
Both facilities are located in the NIH Clinical Center, which largely treats patients who are entered in clinical studies.
An FDA inspection in May 2015 found what the agency termed “significant violations of current good manufacturing practice” at the PDS, such as failing to thoroughly investigate discrepancies in drug batches.
How Health Systems Are Rethinking Facilities Amid Margin Pressure
Ground Broken on New Medical Office Building in Scottsdale, AZ
University of Texas Gifted $100M for New Medical Center
Beyond Backup Generators: Building Layered Energy Resilience
Shannon Health System to Acquire Scenic Mountain Medical Center